MINERALYS THERAPEUTICS INC (MLYS) Stock Analyst Earnings Estimates
NASDAQ:MLYS - Nasdaq - US6031701013 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 908.66% | N/A 237.17% | N/A 100.04% | N/A 42.44% | N/A 31.49% | N/A 25.50% | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A -189.20% | -192.36M -107.59% | N/A -28.42% | N/A -8.20% | N/A -5.30% | N/A 43.51% | N/A 222.37% | N/A 276.82% | N/A 46.65% | N/A 44.00% | |
| EBIT YoY % growth | -2.943M | -18.725M -536.26% | -31.479M -68.11% | -84.657M -168.93% | -192.403M -127.27% | N/A -20.55% | N/A -11.10% | N/A -8.36% | N/A 40.45% | N/A 150.01% | N/A 388.02% | N/A 49.12% | N/A 43.65% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.00 46.36% | -3.64 -82.00% | N/A -10.73% | N/A 5.20% | N/A -4.00% | N/A 42.59% | N/A 153.06% | N/A 312.63% | N/A 37.71% | N/A 24.37% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.10 -57.01% | -1.08 -30.57% | -0.98 13.12% | -0.96 2.42% | -0.83 24.83% | -0.81 25.65% | -0.77 22.08% | -0.82 14.67% |
| Revenue Q2Q % growth | ||||||||
| EBITDA Q2Q % growth | -58.339M -65.01% | -63.297M -40.19% | -46.662M 22.33% | -48.92M 5.42% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -60.864M -72.12% | -61.814M -36.85% | -59.073M 1.72% | -60.462M -16.80% | -65.28M -7.25% | -69.36M -12.21% | -74.46M -26.05% | -79.56M -31.59% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.98 -60.66% | -1.10 | 0.12 | 10.80% |
| Q3 2024 Q2Q % growth | -1.13 -98.25% | -0.85 | -0.28 | -32.79% |
| Q2 2024 Q2Q % growth | -0.83 -167.74% | -0.71 | -0.12 | -16.25% |
| Q1 2024 Q2Q % growth | -0.70 -37.25% | -0.68 | -0.02 | -2.74% |
| Q4 2023 Q2Q % growth | -0.61 64.94% | -0.84 | 0.23 | 27.51% |
| Q3 2023 Q2Q % growth | -0.57 | -0.78 | 0.21 | 26.47% |
| Q2 2023 Q2Q % growth | -0.31 | -0.73 | 0.42 | 57.79% |
| Q1 2023 Q2Q % growth | -0.51 | -0.91 | 0.40 | 43.82% |
| Q4 2022 Q2Q % growth | -1.74 | -1.75 | 0.01 | 0.82% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.48% | 5.48% | -2.73% | -1.17% |
| Revenue | N/A | N/A | N/A | N/A |